400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Anti-infection / HCV / Ruzasvir
CAS No.: 1613081-64-3
Synonyms: MK-8408
Ruzasvir is a potent, Pan-Genotype HCV NS5A inhibitor with Optimized activity against common resistance-associated polymorphisms.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT02661126 | Hepatitis C | Phase 1 | Completed | - | - |
NCT02661126 | - | - | Completed | - | - |
NCT02613403 | Hepatitis Hep... more >>atitis C Digestive System Diseases Flaviviridae Infections Hepatitis, Viral, Human Liver Diseases RNA Virus Infections Virus Diseases Collapse << | Phase 2 | Terminated | - | - |
实验方案
技术信息
CAS号 | 1613081-64-3 | 储存条件 |
|
|
分子式 | C49H55FN10O7S | 运输 | 蓝冰 | |
分子量 | 947.09 | 别名 | MK-8408 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT02661126 | Hepatitis C | Phase 1 | Completed | - | - |
NCT02661126 | - | - | Completed | - | - |
NCT02613403 | Hepatitis Hep... more >>atitis C Digestive System Diseases Flaviviridae Infections Hepatitis, Viral, Human Liver Diseases RNA Virus Infections Virus Diseases Collapse << | Phase 2 | Terminated | - | - |
NCT02613403 | - | - | Terminated | - | - |
NCT02332720 | Hepatitis C | Phase 2 | Completed | - | - |
NCT02759315 | - | - | Terminated(The study was termi... more >>nated based on review of Phase 2 efficacy data) Collapse << | - | - |
NCT02332707 | - | - | Completed | - | - |
NCT02666352 | - | - | Completed | - | - |
NCT02332720 | - | - | Completed | - | - |
NCT02759315 | Hepatitis C, Chronic | Phase 2 | Terminated(The study was termi... more >>nated based on review of Phase 2 efficacy data) Collapse << | - | - |
NCT02076100 | Hepatitis C Infection | Phase 1 | Completed | - | - |
NCT02666352 | Hepatitis C, Chronic | Phase 1 | Completed | - | - |
NCT02956629 | Hepatitis C | Phase 2 | Terminated(The study was termi... more >>nated based on review of Phase 2 efficacy data) Collapse << | - | - |
NCT02332707 | Hepatitis C | Phase 2 | Completed | - | - |
NCT02076100 | - | - | Completed | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网